“O-GlcNAcylation: A Dysregulated Protein Modification with Therapeutic Potential in Diseases”

https://pubmed.ncbi.nlm.nih.gov/38116061

The review highlights that O-GlcNAcylation, a critical protein modification, impacts cellular physiology and is dysregulated in various diseases like diabetes, nervous system degeneration, and cancers, suggesting its potential as a therapeutic target.